The Prognostic Significance of Chromosome 17 Abnormalities in Patients With Myelodysplastic Syndrome Treated With 5‐azacytidine: Results From the Hellenic 5‐azacytidine Registry
Cancer Medicine - United Kingdom
doi 10.1002/cam4.2090
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2019
Authors
Publisher
Wiley